NxThera said today that health insurers Humana and Aetna will now provide coverage for its Rezūm system designed for the minimally invasive treatment of benign prostatic hyperplasia, or enlarged prostate. NxThera’s Rezūm system is designed to use radiofrequency current to create thermal energy to ablate obstructive prostate tissue which causes BPH through targeted treatments. The Maple […]
Urology
7 medtech stories we missed this week: March 3, 2017
Several clinical study results were published this week, while other companies reached distribution deals. Here are 7 medtech stories we missed this week but were still worth mentioning. 1. Health Canada approves Ventripoint’s complete heart analysis system for 2D ultrasounds Ventripoint Diagnostics received a license from Health Canada for its new VMS-Plus machine and the 4-chamber […]
Solace Therapeutics says 3rd trial of Vesair bladder device met endpoints
Solace Therapeutics today released data from a trial of its Vesair bladder control device, touting that the study met its endpoints “with statistical significance.” The Framingham, Mass.-based company’s Vesair bladder control device is comprised of a compressible air-filled balloon which acts as a “shock-abosrber” to slow rapid chanes in pressure that can cause Stress Urinary […]
Augmenix touts more SpaceOar data
Augmenix touted data today from a Phase III trial evaluating its SpaceOar hydrogel in men undergoing prostate radiotherapy. The study showed that the company’s device, placed between the prostate and rectum, helps men maintain sexual function and potency following radiation therapy. Data from the trial demonstrated that the SpaceOar device reduced the median radiation dose […]
Urinary device startup Vesiflo raises $2.4m, looks to bring in $7m
Medical device startup Vesiflo raised $2.4 million in a new round of equity financing to support its iFlow device designed to treat women with impaired detrusor contractility. Funds raised came from 26 unnamed investors, and the company is looking to raise an additional $4.6 million to bring the round to a total of $7 million […]
Boston Sci giving lift to new erectile dysfunction device
Want to put some lead in your pencil? Try nitinol instead. The wonder metal—a nickel-titanium alloy with heat-activated shape memory—has proved essential for Wisconsin and Illinois researchers building what British tabloids are calling a “bionic penis.” Chuckles aside, the proposed implant has enough potential advantages over existing erectile dysfunction treatment implants that Boston Scientific officials […]
Exact Imaging raises $16m in Series C to support ExactVu micro-ultrasound
Micro-ultrasound developer Exact Imaging said today it raised $16.3 million (CDN $21.5 million) in a Series C funding round, with funds slated to support the commercialization of its ExactVu micro-ultrasound system. The round, which closed late last year, was led by Lumira Capital and Vesalius Biocapital and joined by newly invested PMV and previously invested iGan […]
Cook Medical launches Motion 2-in-1 hybrid guidewire
Cook Medical said today it launched the Motion 2-in-1 hybrid wire guide designed for urology procedures. The newly launched device features both a nitinol access guidewire with a Teflon fixed core safety guidewire, the Bloomington, Ind.-based company said. Cook Medical touted the hybrid device, saying the combined guidewires allow clinicians to “streamline” their procedures by reducing […]
iCad deals VersaVue software, DynaCAD to Philips InVivo unit for $3.2m
iCad (NSDQ:ICAD) said yesterday that it agreed to deal its VersaVue software and DynaCAD breast and prostate imaging devices to Royal Philips‘ (NYSE:PHG) InVivo unit for $3.2 million. Nashua, N.H.-based iCad said the Dec. 16 deal includes a holdback reserve of $350,000. The deal is expected to close by Jan. 31, 2017; if it doesn’t close by […]
Insightec’s Exablate wins CE Mark approval for prostate treatment, Japanese approval for essential tremor
Insightec this week announced 2 regulatory wins, receiving CE Mark approval in the European Union for its Exablate Prostate for treating locally-confined prostate cancer and Japanese approval for its Exablate Neuro for treating essential tremor. The Exablate Prostate system uses focused ultrasound to target and ablate tissue in the prostate while minimizing damage to adjacent structures, […]
FDA clears BrightWater Medical’s ConvertX nephroureteral stent
Ureteral medical device company BrightWater Medical said today it won FDA 510(k) clearance for its ConvertX nephroureteral stent system designed for treating ureteral obstructions. The ConvertX System is designed as a single device intended to replace a series of devices and procedures used to treat severe obstructions of the ureter. Traditional interventions require an implanted nephrostomy catheter […]